Brokerages Set Keros Therapeutics, Inc. (NASDAQ:KROS) Price Target at $21.86
Shares of Keros Therapeutics, Inc. (NASDAQ:KROS – Get Free Report) have earned a consensus recommendation of “Hold” from the ten research firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and five have issued a buy recommendation […]
16 Mar 05:44 · The Markets Daily